Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells

Cell Proliferation

Volumn 36, Issue 4, 2003, Pages 199-213

  Truksa, J ^a   Kovar J ^a   Valenta, T ^a   Ehrlichova M ^a   Polak J ^b   Naumann, P W ^c  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; IRON DEPLETION; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAJI CELL; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; GENE EXPRESSION REGULATION; HUMANS; IRON; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE;

EID: 0141836226     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2003.00280.x     Document Type: Article

References (52)

1. ABEYSINGHE RD, GREENE BT, HAYNES R, WILLINGHAM MC, TURNER J, PLANALP RP, BRECHBIEL MV, TORTI FM, TORTI SV (2001) p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Carcinogenesis 22, 1607.
2. ANTONSSON B, CONTI F, CIAVATTA A, MONTESSUIT S, LEWIS S, MARTINOU I, BERNASCONI L, BERNARD A, MERMOD JJ, MAZZEI G, MAUNDRELL K, GAMBALE F, SADOUL R, MARTINOU JC (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370.
3. BHATIA K, GOLDSCHMIDTS W, GUTIERREZ. M, GAIDANO G, DALLA FAVERA R, MAGRATH I (1993) Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenic effect. FASEB J. 7, 951.
4. CHEN TR (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104, 255.
5. CHOMCZYNSKI P, SACCHI N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156.
6. DARNELL G, RICHARDSON DR (1999) The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation. Blood 94, 781.
7. DONFRANCESCO A, DEB G, DE SIO L, COZZA R, CASTELLANO A (1996) Role of deferoxamine in tumor therapy. Acta Haematol. 95, 66.
8. EL-DEIRY WS, TOKINO T, VELCULESCU WE, LEVY DB, PARSONS R, TRENT JM, LIN D, MERCER WE, KINZLER KW, VOOELSTEIN B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell. 75, 817.
9. FARRELL PJ, ALLAN GJ, SHANAHAN F, VOUSDEN KH, CROOK T (1991) p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 10, 2879.
10. FIERS W, BEYAERT R, DECLERQ W, VANDENABEELE P (1999) More than one way to die: apoptosis, necrosis, and reactive oxygen damage. Oncogene 18, 7719.
11. FRADE R, GAUFFRE A, HERMANN J, BAREL M (1992) EBV/C3d receptor (CR2) interacts by its intracytoplasmic carboxy-terminal domain and two distinct binding sites with the p53 anti-oncoprotein and the p68 calcium-binding protein. J. Immunol. 149, 3232.
12. FUKUCHI K, TOMOYASU S, WATANABE H, KAETSU S, TSURUOKA N, GOMI K (1995) Iron deprivation results in an increase in p53 expression. Biol. Chem. Hoppe Seyler 376, 627.
13. HALDAR S, NEGRINI M, MONNE M, SABBIONI S, CROCE CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54, 2095.
14. HAUPT Y, ROWAN S, SHAULIAN E, VOUSDEN KH, OREN M (1995) Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170.
15. HE M, RENNIE PS, DRAGOWSKA V, NELSON CC, JIA W (2002) A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53. FEBS Lett. 517, 151.
16. HOFFMAN B, LIEBERMANN DA (1994) Molecular controls of apoptosis: differentiation/growth arrest primary gene response genes, proto-oncogenes, and tumor supressor genes as positive and negative modulators. Oncogene 9, 1807.
17. HUANG C, ZHANG Z, DING M, LI J, YE J, LEONARD SS, SHEN HM, BUTTERWORTH L, LU Y, COSTA M, ROJANASAKUL Y, CASTRANOVA V, VALLYATHAN V, SHI X (2000) Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem. 275, 32516.
18. IDO Y, MUTO N, INADA A, KOHROKI J, MANO M, ODANI T, ITOH N, YAMAMOTO K, TANAKA K (1999) Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif. 32, 63.
19. JACOBSON MD, WEIL M, RAFF MC (1997) Programmed cell death in animal development. Cell 88, 347.
20. JANUS F, ALBRECHTSEN N, DORNREITER I, WIESMULLER L, GROSSE F, DEPPERT W (1999) The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci. 55, 12.
21. JURGENSMEIER JM, XIE Z, DEVERAUX Q, ELLERBY L, BREDESEN D, REED JC (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 4997.
22. KEMP JD (1997) Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor. Histol. Histopathol. 12, 291.
23. KOVAR J (1988) Growth-stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function. Hybridoma 7, 255.
24. KOVAR J, FRANEK F (1989) Growth-stimulating effect of transferrin on a hybridoma cell line: relation to transferrin iron-transporting function. Exp. Cell Res. 182, 358.
25. KOVAR J, STUNZ LL, STEWART BC, KRIEGERBECKOVA K, ASHMAN RF, KEMP JD (1997) Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. Pathobiology 65, 61.
26. KOVAR J, VALENTA T, STYBROVA H (2001) Differing sensitivity of minor cells to apoptosis induced by iron deprivation in vitro. In Vitro Cell Dev. Biol. Anim. 37, 450.
27. KRUDE T (1999) Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp. Cell Res. 247, 148.
28. KYHSE-ANDERSEN J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Meth 10, 203.
29. LAEMMLI UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680.
30. LEVlNE AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323.
31. LILL R, DIEKERT K, KAUT A, LANGE H, PELZER W, PROHL C, KISPAL G (1999) The essential role of mitochondria in the biogenesis of cellular iron-sulfur proteins. Biol. Chem. 380, 1157.
32. MACLEAN K, PORTER JB (1996) Iron chelators induce apoptosis in thymocytes by mechanisms independent of p53 and DNA synthesis inhibition. European Iron Club Meeting, Jaca; proffered paper.
33. MARZO I, BRENNER C, ZAMZAMI N, JURGENSMEIER JM, SUSIN SA, VIEIRA HL, PREVOST MC, XIE Z, MATSUYAMA S, REED JC, KROEMER G (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027.
34. MIYASHITA T, REED JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293.
35. NELSON WG, KASTAN MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol. 14, 1815.
36. PALLISGAARD N, CLAUSEN N, SCHRODER H, HOKLAND P (1999) Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t (12; 21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer 26, 355.
37. POLLICE AA, MCCoY JP JR, SHACKNEY SE, SMITH CA, AGARWAL J, BURHOLT DR, JANOCKO LE, HORNICEK FJ, SINGH SG, HARTSOCK RJ (1992) Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry 13, 432.
38. RAFF M (1998) Cell suicide for beginners. Nature 396, 119.
39. REICHARD P (1993) From RNA to DNA, why so many ribonucleotide reductases? Science 260, 1773.
40. SCHEFFNER M, WERNESS BA, HUIBREGTSE JM, LEVINE AJ, HOWLEY PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129.
41. SELIGER B, PAPADILERIS S, VOGEL D, HESS G, BRENDEL C, STORKEL S, ORTEL J, KOLBE K, HUBER C, HUHN D, NEUBAUER A (1996) Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur. J. Haematol. 57, 230.
42. SELVAKUMARAN M, LIN HK, MIYASHITA T, WANG HG, KRAJEWSKI S, REED JC, HOFFMAN B, LIEBERMANN D (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9, 1791.
43. SHI XB, NESSLINGER NJ, DEITCH AD, GUMERLOCK PH, DEVERE WHITE RW (2002) Complex functions of mutant p53 alleles from human prostate cancer. Prostate 51, 59.
44. SMITH ML, FORD JM, HOLLANDER MC, BORTNICK RA, AMUNDSON SA, SEO YR, DENG CX, HANAWALT PC, FORNACE AJ JR (2000) p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, 21, anti/or gadd45 genes. Mol. Cell Biol. 20, 3705.
45. SMITH PK, KROHN RI, HERMANSON GT, MALLIA AK, GARTNER FH, PROVENZANO MD, FUJIMOTO EK, GOEKE NM, OLSON BJ, KLENK DC (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76.
46. TAETLE R, HONEYSETT JM, BERGERON R (1989) Combination iron depletion therapy. J. Natl Cancer Inst 81, 1229.
47. TANAKA H, ARAKAWA H, YAMAGUCHI T, SHIRAISHI K, FUKUDA S, MATSUI K, TAKEI Y, NAKAMURA Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42.
48. TANIGUCHI T, ENDO H, CHIKATSU N, UCHIMARU K, ASANO S, FUJITA T, NAKAHATA T, MOTOKURA T (1999) Expression of p21 (Cip1/Waf1/Sdi1) and p27 (Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93, 4167.
49. THOMAS DA, DU C, Xu M, WANG X, LEY TJ (2000) DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity 12, 621.
50. THOMPSON CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456.
51. YAN Y, SHAY JW, WRIGHT WE, MUMBY MC (1997) Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J. Biol. Chem. 272, 15220.
52. YIN Y, SOLOMON G, DENG C, BARRETT JC (1999) Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol. Carcinog. 24, 15.